| Filed On | Filing |
|---|---|
| 16 Oct 2023 |
8-K/A: Financial Statements and Exhibits
(1) Refer to Note 5 "Related Party Transactions" for further detail. |
| 26 Sep 2023 |
8-K/A: Other Events
We have audited the combined financial statements of Magellan Specialty Health (the Company), which comprise the combined balance sheets as of December 31, 2021 and 2020, and the related combined statements of income, net parent investme... |
| 04 Aug 2023 |
8-K/A: Other Events
Evolent Health, Inc. (the “Company”) issued a notice of redemption to the holders of its outstanding 3.50% Convertible Senior Notes due 2024 (the “Notes”) on August 2, 2023, pursuant to which it will redeem the outstanding Notes for cash... |
| 29 Jan 2021 |
8-K/A: Departure/Election of Directors or Officers; Compensation
THIS SEVERANCE AND CHANGE-IN-CONTROL AGREEMENT (this “Agreement”), dated as of January 27, 2021 (the “Effective Date”), is made by and between Evolent Health, Inc., a corporation organized under the laws of the State of Delaware (the “Co... |
| 28 Feb 2020 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying consolidated financial statements of University Health Care, Inc., and Subsidiaries d/b/a Passport Health Plan (a Kentucky non-stock, not‑for‑profit corporation), which comprise the consolidated balance s... |
| 19 Dec 2016 |
8-K/A: Financial Statements and Exhibits
Evolent Health, Inc. (“Evolent,” the “Company,” “we,” or “our,”) was incorporated as a Delaware corporation on December 12, 2014, for the purpose of pursuing the Company’s Initial Public Offering (“IPO”). Immediately prior to the complet... |
Loading...